These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32124413)
1. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study. Jhaveri M; Nair AB; Shah J; Jacob S; Patel V; Mehta T Drug Deliv Transl Res; 2020 Aug; 10(4):975-985. PubMed ID: 32124413 [TBL] [Abstract][Full Text] [Related]
2. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation. Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study. Sharma M; Sharma R; Jain DK; Saraf A Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197 [TBL] [Abstract][Full Text] [Related]
4. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
6. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach. Jaydip B; Dhaval M; Soniwala MM; Chavda J Saudi Pharm J; 2020 Jun; 28(6):737-745. PubMed ID: 32550806 [TBL] [Abstract][Full Text] [Related]
8. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin. Kamble PR; Shaikh KS; Chaudhari PD Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations. Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670 [TBL] [Abstract][Full Text] [Related]
11. Solubility enhancement effect at absorption site on bioavailability of ritonavir using liquisolid technique. Bonthagarala B; Dasari V; Kotra V Ther Deliv; 2019 May; 10(5):295-310. PubMed ID: 31094300 [No Abstract] [Full Text] [Related]
12. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Javadzadeh Y; Musaalrezaei L; Nokhodchi A Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643 [TBL] [Abstract][Full Text] [Related]
13. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design. Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252 [TBL] [Abstract][Full Text] [Related]
14. Quality-by-Design-Based Development of Rivaroxaban-Loaded Liquisolid Compact Tablets with Improved Biopharmaceutical Attributes. Shah P; Desai H; Vyas B; Lalan M; Kulkarni M AAPS PharmSciTech; 2023 Aug; 24(7):176. PubMed ID: 37639081 [TBL] [Abstract][Full Text] [Related]
16. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594 [TBL] [Abstract][Full Text] [Related]
17. Development of Solid Dispersion by Hot Melt Extrusion Using Mixtures of Polyoxylglycerides With Polymers as Carriers for Increasing Dissolution Rate of a Poorly Soluble Drug Model. Vasoya JM; Desai HH; Gumaste SG; Tillotson J; Kelemen D; Dalrymple DM; Serajuddin ATM J Pharm Sci; 2019 Feb; 108(2):888-896. PubMed ID: 30257196 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of ketoconazole dissolution rate by the liquisolid technique. Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692 [TBL] [Abstract][Full Text] [Related]
19. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)]. Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032 [TBL] [Abstract][Full Text] [Related]
20. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release. El-Hammadi M; Awad N AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]